Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bharat Biotech announces Phase 3 results of COVAXIN®: India's first COVID-19 vaccine demonstrates interim clinical efficacy of 81%

worldpharmanewsMarch 22, 2021

Tag: Bharat Biotech , COVID-19 vaccine , Covaxin , BBV152

PharmaSources Customer Service